Essa Pharma Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview

ESSA Pharma

31/07/2023 14:43

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on August 2
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for ESSA Pharma Inc is
for a
loss of 19 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $17​, above​ its last closing price of $2.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.20       -0.20      -0.16     Beat    22
 Dec. 31 2023  -0.22       -0.23      -0.15     Beat    36.2
 Sep. 30 2022              -0.27      -0.14     Beat    49.1​
 Jun. 30 2022  -0.28       -0.27      -0.20     Beat    25.9
 ​​Mar.        -0.26       -0.25      -0.25     Met     1
 31 2022                                                
 Dec. 31 2021  -0.23       -0.23      -0.21     Beat    8.7​
 Sep. 30 2021  -0.22       -0.23      -0.20     Beat    14
 Jun. 30 2021  -0.26       -0.26      -0.21     Beat    20
 This summary was machine generated July 31 at 13:43 GMT.  All
figures in US dollars  unless otherwise stated